Vaccine candidate shows very promising results

That candidate vaccine has been around for some time now. Trump didn't have anything to do with it's development.

The report is all about Trump's recent attempt to hijack the vaccine band-waggon in the hope that it may help his chances of getting re-elected in November.

It does assume that there will be enough America left in November to make it worth the trouble of polling the survivors.

ve anything to do with it's development.

-waggon in the hope that it may help his chances of getting re-elected in N ovember.

e it worth the trouble of polling the survivors.

That's the liposome encapsulating the mRNA technology, which has been aroun d for decades, there's no reason this should be a surprise. They have used the same technique to develop commercially available vaccines for influenza and hepatitis-A. The drawback is the precision manufacturing required, it may not be as "scalable" as they claim and it may be difficult to produce i n the quantities they need. Looks like they will be going with the 50-100 u g dose, that's huge when you start talking about 300 million doses, actuall y 600 million since this one requires a second booster shot. And it takes 6 weeks to develop immunity, which has not been tested for durability. Moder na has not been forthcoming with the full results of their trial which is s uspicious. They're more interested in the surge in their stock market value .

Do some diligence of where Trump's Czar comes from . (Sorrento Board of Dir ectors) Then imagine what the rumors spread 2 days before Trump's announcement of n egative Q2 earnings did after Sorrento released a bullish statement of 100% cure rate based on no Stage 2 or 3 trials. Well the stock eent viral to 40

Moderna has already made 400% based on very risky expensive technology to p urify immunoglobulin of other problems. But will be in the race like the 4 Chinese Companies.

BTW who else is suspicious that Sorrento's CEO graduated in China has CCP s upport?